Annual report pursuant to Section 13 and 15(d)

Note 4 - Acquisition (Tables)

v3.24.1.u1
Note 4 - Acquisition (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Business Acquisition, Pro Forma Information [Table Text Block]
   

For the Twelve Months Ended December 31, 2023

   

For the Year Ended December 31, 2022

 
   

(Unaudited)

   

(Unaudited)

 

Revenue

  $ 60,704     $ 52,312  
                 

Earnings

  $ (15,854 )   $ (13,867 )
Schedule of Business Acquisitions, by Acquisition [Table Text Block]
         
   

Purchase Price Allocation

 

Total purchase consideration

  $ 16,679  

Fair value of non-controlling interest

    23,180  

Total consideration

  $ 39,859  
         

Identifiable net assets acquired:

       

Cash

  $ 7,352  

Accounts receivable, net

    6,478  

Accounts receivable, other

    506  

Inventory

    1,631  

Prepaid expenses

    220  

Property and equipment, net

    2,883  

Right of use assets, net

    405  

Intangible assets, net:

       

Trade name

    4,700  

Development technology

    2,880  

Pharmacy records

    8,130  

Deposits

    39  

Accounts payable and accrued expenses

    (8,231 )

Notes payable and accrued interest - current portion

    (149 )

Lease liabilities - current portion

    (208 )

Notes payable - long term

    (1,173 )

Lease liabilities - long term

    (230 )

Deferred tax liability (1)

    -  

Net assets acquired

  $ 25,233  
         

Goodwill

  $ 14,626